Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

عرض إصدارات أخرى (1)

OBJECTIVES: Reports have suggested that a reduction in tumour 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) examination during or after neoadjuvant chemotherapy may predict pathological response in oesophageal cancer. Our aim was to determine whether metabolic response pr...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Gillies, R, Middleton, MR, Blesing, C, Patel, K, Warner, N, Marshall, R, Maynard, N, Bradley, K, Gleeson, F
التنسيق:	Journal article
اللغة:	English
منشور في:	2012

مواد مشابهة

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
حسب: Gillies, R, وآخرون
منشور في: (2012)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
حسب: Findlay, J, وآخرون
منشور في: (2017)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
حسب: Gillies, R, وآخرون
منشور في: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
حسب: Gillies, R, وآخرون
منشور في: (2012)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
حسب: Findlay, J, وآخرون
منشور في: (2017)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
حسب: Gillies, R, وآخرون
منشور في: (2011)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
حسب: Gillies, R, وآخرون
منشور في: (2011)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
حسب: Gillies, R, وآخرون
منشور في: (2010)

Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy
حسب: Findlay, J, وآخرون
منشور في: (2016)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
حسب: Teoh, S, وآخرون
منشور في: (2016)

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
حسب: Chowdhury, F, وآخرون
منشور في: (2008)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
حسب: Millo, J, وآخرون
منشور في: (2003)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
حسب: Findlay, J, وآخرون
منشور في: (2016)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
حسب: Rana, M, وآخرون
منشور في: (2021)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
حسب: den Boer, RB, وآخرون
منشور في: (2020)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
حسب: John M. Findlay, وآخرون
منشور في: (2016-04-01)

A reply to evidence-based radiation oncology: oesophagus.
حسب: Gillies, R, وآخرون
منشور في: (2010)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
حسب: Kieran G. Foley, وآخرون
منشور في: (2021-06-01)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
حسب: Teoh, S, وآخرون
منشور في: (2018)

Assessment of Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and 18F FDG PET/CT
حسب: Reem Yusuf AlBuainain, وآخرون
منشور في: (2025-01-01)

Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
حسب: Tarik Sengoz, وآخرون
منشور في: (2023-04-01)

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
حسب: Han Wonshik, وآخرون
منشور في: (2011-10-01)

PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
حسب: Chowdhury, F, وآخرون
منشور في: (2009)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
حسب: A. G. M. T. Powell, وآخرون
منشور في: (2020-08-01)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
حسب: Alexander M Th Schmitz, وآخرون
منشور في: (2017-01-01)

Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
حسب: Lihua Chen, وآخرون
منشور في: (2017-08-01)

Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery
حسب: Findlay, J, وآخرون
منشور في: (2019)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
حسب: Turkington, RC, وآخرون
منشور في: (2019)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
حسب: M. K. Ibragimova, وآخرون
منشور في: (2022-03-01)

Clinical value of SUVpeak-to-tumor centroid distance on FDG PET/CT for predicting neoadjuvant chemotherapy response in patients with breast cancer
حسب: Sun-pyo Hong, وآخرون
منشور في: (2024-10-01)

Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
حسب: Sangwon Han, وآخرون
منشور في: (2020-10-01)

Efficacy Of 18FDG-PET/CT In Predicting Response After Neoadjuvant Chemoradiation In Rectal Cancer
حسب: Narendra Pandit, وآخرون
منشور في: (2023-08-01)

Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer
حسب: Inci Kizildag Yirgin, وآخرون
منشور في: (2020-01-01)

The Role of Pretreatment 18F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
حسب: Yao J, وآخرون
منشور في: (2021-10-01)

Predictors of complete response to neoadjuvant chemotherapy in non-metastatic bladder cancer
حسب: P. Sousa Passos, وآخرون
منشور في: (2020-11-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy. Additional material
حسب: M. K. Ibragimova, وآخرون
منشور في: (2022-03-01)

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
حسب: Rui-Qin Zhou, وآخرون
منشور في: (2023-05-01)

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
حسب: Giulia Polverari, وآخرون
منشور في: (2020-10-01)

Correlation Between 18F-FDG PET/CT SUVmax and Clinicopathological Features, Neoadjuvant Chemotherapy Response in Invasive Ductal Breast Carcinoma Patients
حسب: LU Shengnan, وآخرون
منشور في: (2019-02-01)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
حسب: Willard Wong, وآخرون
منشور في: (2021-07-01)